Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks.
about
Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Response by gender of HIV-1-in ...... hout ritonavir, for 144 weeks.
@en
Response by gender of HIV-1-in ...... hout ritonavir, for 144 weeks.
@nl
type
label
Response by gender of HIV-1-in ...... hout ritonavir, for 144 weeks.
@en
Response by gender of HIV-1-in ...... hout ritonavir, for 144 weeks.
@nl
prefLabel
Response by gender of HIV-1-in ...... hout ritonavir, for 144 weeks.
@en
Response by gender of HIV-1-in ...... hout ritonavir, for 144 weeks.
@nl
P2093
P2860
P356
P1476
Response by gender of HIV-1-in ...... thout ritonavir, for 144 weeks
@en
P2093
Benjamin Young
Gary E Pakes
Henry H Zhao
Kathleen E Squires
Lisa L Ross
Lizette Santiago
Mark S Shaefer
Robin H Dretler
P2860
P356
10.2147/HIV.S108756
P407
P50
P577
2017-03-03T00:00:00Z